Adiponectin decreases low density lipoprotein (LDL) receptor expression in breast cancer cells through promoting autophagic flux and inhibits LDL-cholesterol-induced tumor cell proliferation [127]. This evidence concerns the gene ADIPOQ and breast cancer.